Galenica AG (LON:0ROG)
101.70
+1.39 (1.38%)
Feb 12, 2026, 4:31 PM GMT
Galenica AG Revenue
Galenica AG had revenue of 2.00B CHF in the half year ending June 30, 2025, with 7.77% growth. This brings the company's revenue in the last twelve months to 4.03B, up 5.91% year-over-year. In the year 2024, Galenica AG had annual revenue of 3.93B with 4.65% growth.
Revenue (ttm)
4.03B CHF
Revenue Growth
+5.91%
P/S Ratio
1.31
Revenue / Employee
504.07K CHF
Employees
7,991
Market Cap
4.84B GBP
Revenue Chart
* This company reports financials in CHF.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.93B | 174.55M | 4.65% |
| Dec 31, 2023 | 3.76B | 160.81M | 4.47% |
| Dec 31, 2022 | 3.60B | -246.19M | -6.41% |
| Dec 31, 2021 | 3.84B | 356.57M | 10.23% |
| Dec 31, 2020 | 3.48B | 178.60M | 5.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.64B |
| GSK plc | 32.67B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| Convatec Group | 1.72B |
| CVS Group | 673.20M |
| Genus | 672.80M |
Galenica AG News
- 3 months ago - Galenica AG (GALNF) Analyst/Investor Day - Slideshow - Seeking Alpha